Recursion Pharmaceuticals, Inc. SEC filings RXRX
Recursion Pharmaceuticals, Inc. has 991 filings in SEC EDGAR's recent list, going back to Apr 2, 2014. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 2, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (results of operations, officer or director change, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| UPLOAD | Letter from the SEC | Jun 13, 2024 | — |
| CORRESP | Letter to the SEC | Jun 13, 2024 | — |
| UPLOAD | Letter from the SEC | May 30, 2024 | — |
| SEC STAFF LETTER | Filing | Apr 15, 2021 | — |
| EFFECT | Filing | Apr 15, 2021 | — |
| CERT | Filing | Apr 15, 2021 | — |
| CORRESP | Letter to the SEC | Apr 13, 2021 | — |
| CORRESP | Letter to the SEC | Apr 13, 2021 | — |
| 8-A12B | Filing | Apr 12, 2021 | — |
| SEC STAFF LETTER | Filing | Mar 25, 2021 | — |
| CORRESP | Letter to the SEC | Mar 22, 2021 | — |
| UPLOAD | Letter from the SEC | Mar 19, 2021 | — |
| DRSLTR | Filing | Mar 3, 2021 | — |
| DRS/A | Filing | Mar 3, 2021 | — |
| UPLOAD | Letter from the SEC | Feb 22, 2021 | — |
| DRS | Filing | Jan 26, 2021 | — |
| D/A | Filing | Nov 12, 2020 | — |
| D | Filing | Sep 15, 2020 | — |
| D | Filing | Aug 13, 2019 | — |
| D | Filing | Oct 6, 2017 | — |
| D/A | Filing | Dec 2, 2016 | — |
| D | Filing | Sep 14, 2016 | — |
| D | Filing | Sep 14, 2016 | — |
| D | Filing | Sep 14, 2016 | — |
| D | Filing | Dec 4, 2015 | — |
| D | Filing | Feb 23, 2015 | — |
| D/A | Filing | Apr 2, 2014 | — |
| D | Filing | Apr 2, 2014 | — |
Showing 28 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- RXRX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Salt Lake City, UT
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1601830
- Former names
- Recursion Pharmaceuticals, LLC (until Dec 4, 2015)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.